Cassava Sciences' Phase 3 trial for Alzheimer's failed to meet primary or secondary endpoints, leading to the discontinuation ...

BridgeBio’s Attruby wins approval for transthyretin amyloid cardiomyopathy while the FDA accepts Alnylam’s application for ...

Cassava Sciences, Inc., a clinical-stage biotechnology company focused on developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, announced that the topline results from ...

NEW YORK, NY / ACCESSWIRE / November 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cassava ...

Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...

Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Anavex Life Sciences (AVXL – Research Report) today and set a price target of ...

Want to get stronger and burn lots of calories in the process without going to the gym? Buy yourself a kettlebell and do this ...

We spoke with the Vigo Co. Health Department about how to properly manage your food and leftovers on Thanksgiving. Public ...

US & Canada, Nov. 27, 2024 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the Global ...

Parliament's winter session began with disruptions as the opposition clashed with the ruling party. Prime Minister Modi accused the opposition of obstructing proceedings, while the INDIA bloc ...

A brawl erupted between a Thai transwoman and a foreign man at a hotel in Phuket after the foreigner refused to pay upon discovering her gender. A source, who wishes to remain anonymous, reported the ...